@article{9cf14c2928c648d79eb02f5c34fd932d,
title = "Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis",
author = "Isabel Mortimer and Bissell, \{Lesley Anne\} and Hensor, \{Elizabeth M.A.\} and Lukasz Kozera and MacKie, \{Sarah L.\} and Burska, \{Agata N.\} and Nam, \{Jackie L.\} and Helen Keen and Edith Villeneuve and Helena Donica and Buch, \{Maya H.\} and Conaghan, \{Philip G.\} and Paul Emery and Morgan, \{Ann W.\} and Jacqueline Andrews",
note = "Funding Information: Funding: This study was funded internally and supported by the National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, NIHR Leeds Clinical Research Facility and Diagnostic Evaluation Co-operative and a research grant from the investigator-initiated studies program of Merck Sharp \& Dohme. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, the Department of Health or Merck Sharp \& Dohme. Funding Information: Disclosure statement: P.G.C. has participated in speakers bureaus or consulted for AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer and Roche. M.H.B. has received research grant support and/or honoraria/consultancy fees from Pfizer, Roche-Chugai and UCB; has received honoraria/consultancy fees from AbbVie, Aurora, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Sandoz and Sanofi. P.E. has undertaken clinical trials and provided expert advice to Pfizer, Merck Sharp \& Dohme, AbbVie, Bristol-Myers Squibb, UCB, Roche, Novartis, Samsung, Sandoz and Ely Lilly. E.V. has received consulting fees from AbbVie, Amgen, Bristol-Myers Squibb, Janssen and UCB and research support from AbbVie. H.K. has received honoraria from Janssen and research support from Centocor and Schering-Plough. A.W.M. has received research grant support and/or honoraria/consultancy fees from Merck Sharp \& Dohme, Roche-Chugai, GlaxoSmithKline and Sanofi. L.A.B. has received honoraria from UCB. The other authors have declared no conflicts of interest.",
year = "2019",
month = sep,
day = "1",
doi = "10.1093/rheumatology/kez114",
language = "English",
volume = "58",
pages = "1684--1686",
journal = "Rheumatology (United Kingdom)",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "9",
}